Asthma Drugs Market Outlook (2022-2033)

The Asthma Drugs Market size is expected to reach US$ 40.04 Billion by 2033 from US$ 29.3 Billion in 2025. The market is estimated to record a CAGR of 3.98% from 2026 to 2033.

Report Coverage
  • Medication: Quick Relief Medication, Long Term Control Medications
  • Drug Class: Bronchodilators, Corticosteroids, Leukotriene modifiers, Combination medications, Other Drug Class
  • Mode of Administration: Inhaler, Prefilled Syringe/Vials, Tablet and Capsules, Liquid Preparation
  • Age Group: Pediatric, Adults
US$ 29.3 Bn Market size in 2025
US$ 40.04 Bn Market Size by 2033
3.98% CAGR, 2026 - 2033
2026-2033 Forecast Period

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Asthma Drugs Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Asthma Drugs Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Asthma Drugs Market Global Analysis

6.2 Asthma Drugs Market Revenue 2022-2033 (US$ Billion)
6.3 Asthma Drugs Market Forecast Analysis

7. Asthma Drugs Market Analysis – by Medication

7.1 Quick Relief Medication
  • 7.1.1 Overview
  • 7.1.2 Quick Relief Medication: Asthma Drugs Market – Revenue and Forecast, 2022-2033 (US$ Billion)
7.2 Long Term Control Medications
  • 7.2.1 Overview
  • 7.2.2 Long Term Control Medications: Asthma Drugs Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8. Asthma Drugs Market Analysis – by Drug Class

8.1 Bronchodilators
  • 8.1.1 Overview
  • 8.1.2 Bronchodilators: Asthma Drugs Market – Revenue and Forecast, 2022-2033 (US$ Billion)
8.2 Corticosteroids
  • 8.2.1 Overview
  • 8.2.2 Corticosteroids: Asthma Drugs Market – Revenue and Forecast, 2022-2033 (US$ Billion)
8.3 Leukotriene modifiers
  • 8.3.1 Overview
  • 8.3.2 Leukotriene modifiers: Asthma Drugs Market – Revenue and Forecast, 2022-2033 (US$ Billion)
8.4 Combination medications
  • 8.4.1 Overview
  • 8.4.2 Combination medications: Asthma Drugs Market – Revenue and Forecast, 2022-2033 (US$ Billion)
8.5 Other Drug Class
  • 8.5.1 Overview
  • 8.5.2 Other Drug Class: Asthma Drugs Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9. Asthma Drugs Market Analysis – by Mode of Administration

9.1 Inhaler
  • 9.1.1 Overview
  • 9.1.2 Inhaler: Asthma Drugs Market – Revenue and Forecast, 2022-2033 (US$ Billion)
9.2 Prefilled Syringe/Vials
  • 9.2.1 Overview
  • 9.2.2 Prefilled Syringe/Vials: Asthma Drugs Market – Revenue and Forecast, 2022-2033 (US$ Billion)
9.3 Tablet and Capsules
  • 9.3.1 Overview
  • 9.3.2 Tablet and Capsules: Asthma Drugs Market – Revenue and Forecast, 2022-2033 (US$ Billion)
9.4 Liquid Preparation
  • 9.4.1 Overview
  • 9.4.2 Liquid Preparation: Asthma Drugs Market – Revenue and Forecast, 2022-2033 (US$ Billion)

10. Asthma Drugs Market Analysis – by Age Group

10.1 Pediatric
  • 10.1.1 Overview
  • 10.1.2 Pediatric: Asthma Drugs Market – Revenue and Forecast, 2022-2033 (US$ Billion)
10.2 Adults
  • 10.2.1 Overview
  • 10.2.2 Adults: Asthma Drugs Market – Revenue and Forecast, 2022-2033 (US$ Billion)

11. Asthma Drugs Market – Geographic Analysis

11.1 Overview

11.2 North America
  • 11.2.1 Asthma Drugs Market Breakdown, by Key Country, 2026 and 2033 (%)
  • 11.2.1.1 Asthma Drugs Market – Revenue and Forecast Analysis – by Country
  • 11.2.1.1 US: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.2.1.1.1 US: Asthma Drugs Market Breakdown, by Medication
    • 11.2.1.1.2 US: Asthma Drugs Market Breakdown, by Drug Class
    • 11.2.1.1.3 US: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.2.1.1.4 US: Asthma Drugs Market Breakdown, by Age Group
  • 11.2.1.2 Canada: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.2.1.2.1 Canada: Asthma Drugs Market Breakdown, by Medication
    • 11.2.1.2.2 Canada: Asthma Drugs Market Breakdown, by Drug Class
    • 11.2.1.2.3 Canada: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.2.1.2.4 Canada: Asthma Drugs Market Breakdown, by Age Group
  • 11.2.1.3 Mexico : Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.2.1.3.1 Mexico : Asthma Drugs Market Breakdown, by Medication
    • 11.2.1.3.2 Mexico : Asthma Drugs Market Breakdown, by Drug Class
    • 11.2.1.3.3 Mexico : Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.2.1.3.4 Mexico : Asthma Drugs Market Breakdown, by Age Group
11.3 Europe
  • 11.3.1 Asthma Drugs Market Breakdown, by Key Country, 2026 and 2033 (%)
  • 11.3.1.1 Asthma Drugs Market – Revenue and Forecast Analysis – by Country
  • 11.3.1.1 Belgium: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.3.1.1.1 Belgium: Asthma Drugs Market Breakdown, by Medication
    • 11.3.1.1.2 Belgium: Asthma Drugs Market Breakdown, by Drug Class
    • 11.3.1.1.3 Belgium: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.3.1.1.4 Belgium: Asthma Drugs Market Breakdown, by Age Group
  • 11.3.1.2 Austria: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.3.1.2.1 Austria: Asthma Drugs Market Breakdown, by Medication
    • 11.3.1.2.2 Austria: Asthma Drugs Market Breakdown, by Drug Class
    • 11.3.1.2.3 Austria: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.3.1.2.4 Austria: Asthma Drugs Market Breakdown, by Age Group
  • 11.3.1.3 Finland: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.3.1.3.1 Finland: Asthma Drugs Market Breakdown, by Medication
    • 11.3.1.3.2 Finland: Asthma Drugs Market Breakdown, by Drug Class
    • 11.3.1.3.3 Finland: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.3.1.3.4 Finland: Asthma Drugs Market Breakdown, by Age Group
  • 11.3.1.4 Denmark: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.3.1.4.1 Denmark: Asthma Drugs Market Breakdown, by Medication
    • 11.3.1.4.2 Denmark: Asthma Drugs Market Breakdown, by Drug Class
    • 11.3.1.4.3 Denmark: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.3.1.4.4 Denmark: Asthma Drugs Market Breakdown, by Age Group
  • 11.3.1.5 Greece: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.3.1.5.1 Greece: Asthma Drugs Market Breakdown, by Medication
    • 11.3.1.5.2 Greece: Asthma Drugs Market Breakdown, by Drug Class
    • 11.3.1.5.3 Greece: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.3.1.5.4 Greece: Asthma Drugs Market Breakdown, by Age Group
  • 11.3.1.6 Poland: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.3.1.6.1 Poland: Asthma Drugs Market Breakdown, by Medication
    • 11.3.1.6.2 Poland: Asthma Drugs Market Breakdown, by Drug Class
    • 11.3.1.6.3 Poland: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.3.1.6.4 Poland: Asthma Drugs Market Breakdown, by Age Group
  • 11.3.1.7 Romania: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.3.1.7.1 Romania: Asthma Drugs Market Breakdown, by Medication
    • 11.3.1.7.2 Romania: Asthma Drugs Market Breakdown, by Drug Class
    • 11.3.1.7.3 Romania: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.3.1.7.4 Romania: Asthma Drugs Market Breakdown, by Age Group
  • 11.3.1.8 Russia: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.3.1.8.1 Russia: Asthma Drugs Market Breakdown, by Medication
    • 11.3.1.8.2 Russia: Asthma Drugs Market Breakdown, by Drug Class
    • 11.3.1.8.3 Russia: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.3.1.8.4 Russia: Asthma Drugs Market Breakdown, by Age Group
  • 11.3.1.9 Ukraine: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.3.1.9.1 Ukraine: Asthma Drugs Market Breakdown, by Medication
    • 11.3.1.9.2 Ukraine: Asthma Drugs Market Breakdown, by Drug Class
    • 11.3.1.9.3 Ukraine: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.3.1.9.4 Ukraine: Asthma Drugs Market Breakdown, by Age Group
  • 11.3.1.10 Czech Republic: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.3.1.10.1 Czech Republic: Asthma Drugs Market Breakdown, by Medication
    • 11.3.1.10.2 Czech Republic: Asthma Drugs Market Breakdown, by Drug Class
    • 11.3.1.10.3 Czech Republic: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.3.1.10.4 Czech Republic: Asthma Drugs Market Breakdown, by Age Group
  • 11.3.1.11 Slovakia: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.3.1.11.1 Slovakia: Asthma Drugs Market Breakdown, by Medication
    • 11.3.1.11.2 Slovakia: Asthma Drugs Market Breakdown, by Drug Class
    • 11.3.1.11.3 Slovakia: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.3.1.11.4 Slovakia: Asthma Drugs Market Breakdown, by Age Group
  • 11.3.1.12 Bulgaria: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.3.1.12.1 Bulgaria: Asthma Drugs Market Breakdown, by Medication
    • 11.3.1.12.2 Bulgaria: Asthma Drugs Market Breakdown, by Drug Class
    • 11.3.1.12.3 Bulgaria: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.3.1.12.4 Bulgaria: Asthma Drugs Market Breakdown, by Age Group
  • 11.3.1.13 Italy: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.3.1.13.1 Italy: Asthma Drugs Market Breakdown, by Medication
    • 11.3.1.13.2 Italy: Asthma Drugs Market Breakdown, by Drug Class
    • 11.3.1.13.3 Italy: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.3.1.13.4 Italy: Asthma Drugs Market Breakdown, by Age Group
  • 11.3.1.14 Luxembourg: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.3.1.14.1 Luxembourg: Asthma Drugs Market Breakdown, by Medication
    • 11.3.1.14.2 Luxembourg: Asthma Drugs Market Breakdown, by Drug Class
    • 11.3.1.14.3 Luxembourg: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.3.1.14.4 Luxembourg: Asthma Drugs Market Breakdown, by Age Group
  • 11.3.1.15 Germany: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.3.1.15.1 Germany: Asthma Drugs Market Breakdown, by Medication
    • 11.3.1.15.2 Germany: Asthma Drugs Market Breakdown, by Drug Class
    • 11.3.1.15.3 Germany: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.3.1.15.4 Germany: Asthma Drugs Market Breakdown, by Age Group
  • 11.3.1.16 Switzerland: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.3.1.16.1 Switzerland: Asthma Drugs Market Breakdown, by Medication
    • 11.3.1.16.2 Switzerland: Asthma Drugs Market Breakdown, by Drug Class
    • 11.3.1.16.3 Switzerland: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.3.1.16.4 Switzerland: Asthma Drugs Market Breakdown, by Age Group
  • 11.3.1.17 France: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.3.1.17.1 France: Asthma Drugs Market Breakdown, by Medication
    • 11.3.1.17.2 France: Asthma Drugs Market Breakdown, by Drug Class
    • 11.3.1.17.3 France: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.3.1.17.4 France: Asthma Drugs Market Breakdown, by Age Group
  • 11.3.1.18 Netherlands: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.3.1.18.1 Netherlands: Asthma Drugs Market Breakdown, by Medication
    • 11.3.1.18.2 Netherlands: Asthma Drugs Market Breakdown, by Drug Class
    • 11.3.1.18.3 Netherlands: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.3.1.18.4 Netherlands: Asthma Drugs Market Breakdown, by Age Group
  • 11.3.1.19 Norway: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.3.1.19.1 Norway: Asthma Drugs Market Breakdown, by Medication
    • 11.3.1.19.2 Norway: Asthma Drugs Market Breakdown, by Drug Class
    • 11.3.1.19.3 Norway: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.3.1.19.4 Norway: Asthma Drugs Market Breakdown, by Age Group
  • 11.3.1.20 Portugal: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.3.1.20.1 Portugal: Asthma Drugs Market Breakdown, by Medication
    • 11.3.1.20.2 Portugal: Asthma Drugs Market Breakdown, by Drug Class
    • 11.3.1.20.3 Portugal: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.3.1.20.4 Portugal: Asthma Drugs Market Breakdown, by Age Group
  • 11.3.1.21 Spain: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.3.1.21.1 Spain: Asthma Drugs Market Breakdown, by Medication
    • 11.3.1.21.2 Spain: Asthma Drugs Market Breakdown, by Drug Class
    • 11.3.1.21.3 Spain: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.3.1.21.4 Spain: Asthma Drugs Market Breakdown, by Age Group
  • 11.3.1.22 Sweden: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.3.1.22.1 Sweden: Asthma Drugs Market Breakdown, by Medication
    • 11.3.1.22.2 Sweden: Asthma Drugs Market Breakdown, by Drug Class
    • 11.3.1.22.3 Sweden: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.3.1.22.4 Sweden: Asthma Drugs Market Breakdown, by Age Group
  • 11.3.1.23 United Kingdom : Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.3.1.23.1 United Kingdom : Asthma Drugs Market Breakdown, by Medication
    • 11.3.1.23.2 United Kingdom : Asthma Drugs Market Breakdown, by Drug Class
    • 11.3.1.23.3 United Kingdom : Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.3.1.23.4 United Kingdom : Asthma Drugs Market Breakdown, by Age Group
11.4 Asia-Pacific
  • 11.4.1 Asthma Drugs Market Breakdown, by Key Country, 2026 and 2033 (%)
  • 11.4.1.1 Asthma Drugs Market – Revenue and Forecast Analysis – by Country
  • 11.4.1.1 Australia: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.4.1.1.1 Australia: Asthma Drugs Market Breakdown, by Medication
    • 11.4.1.1.2 Australia: Asthma Drugs Market Breakdown, by Drug Class
    • 11.4.1.1.3 Australia: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.4.1.1.4 Australia: Asthma Drugs Market Breakdown, by Age Group
  • 11.4.1.2 China: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.4.1.2.1 China: Asthma Drugs Market Breakdown, by Medication
    • 11.4.1.2.2 China: Asthma Drugs Market Breakdown, by Drug Class
    • 11.4.1.2.3 China: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.4.1.2.4 China: Asthma Drugs Market Breakdown, by Age Group
  • 11.4.1.3 India: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.4.1.3.1 India: Asthma Drugs Market Breakdown, by Medication
    • 11.4.1.3.2 India: Asthma Drugs Market Breakdown, by Drug Class
    • 11.4.1.3.3 India: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.4.1.3.4 India: Asthma Drugs Market Breakdown, by Age Group
  • 11.4.1.4 Japan: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.4.1.4.1 Japan: Asthma Drugs Market Breakdown, by Medication
    • 11.4.1.4.2 Japan: Asthma Drugs Market Breakdown, by Drug Class
    • 11.4.1.4.3 Japan: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.4.1.4.4 Japan: Asthma Drugs Market Breakdown, by Age Group
  • 11.4.1.5 South Korea: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.4.1.5.1 South Korea: Asthma Drugs Market Breakdown, by Medication
    • 11.4.1.5.2 South Korea: Asthma Drugs Market Breakdown, by Drug Class
    • 11.4.1.5.3 South Korea: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.4.1.5.4 South Korea: Asthma Drugs Market Breakdown, by Age Group
  • 11.4.1.6 Indonesia: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.4.1.6.1 Indonesia: Asthma Drugs Market Breakdown, by Medication
    • 11.4.1.6.2 Indonesia: Asthma Drugs Market Breakdown, by Drug Class
    • 11.4.1.6.3 Indonesia: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.4.1.6.4 Indonesia: Asthma Drugs Market Breakdown, by Age Group
  • 11.4.1.7 Malaysia: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.4.1.7.1 Malaysia: Asthma Drugs Market Breakdown, by Medication
    • 11.4.1.7.2 Malaysia: Asthma Drugs Market Breakdown, by Drug Class
    • 11.4.1.7.3 Malaysia: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.4.1.7.4 Malaysia: Asthma Drugs Market Breakdown, by Age Group
  • 11.4.1.8 Philippines: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.4.1.8.1 Philippines: Asthma Drugs Market Breakdown, by Medication
    • 11.4.1.8.2 Philippines: Asthma Drugs Market Breakdown, by Drug Class
    • 11.4.1.8.3 Philippines: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.4.1.8.4 Philippines: Asthma Drugs Market Breakdown, by Age Group
  • 11.4.1.9 Singapore: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.4.1.9.1 Singapore: Asthma Drugs Market Breakdown, by Medication
    • 11.4.1.9.2 Singapore: Asthma Drugs Market Breakdown, by Drug Class
    • 11.4.1.9.3 Singapore: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.4.1.9.4 Singapore: Asthma Drugs Market Breakdown, by Age Group
  • 11.4.1.10 Thailand: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.4.1.10.1 Thailand: Asthma Drugs Market Breakdown, by Medication
    • 11.4.1.10.2 Thailand: Asthma Drugs Market Breakdown, by Drug Class
    • 11.4.1.10.3 Thailand: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.4.1.10.4 Thailand: Asthma Drugs Market Breakdown, by Age Group
  • 11.4.1.11 Vietnam: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.4.1.11.1 Vietnam: Asthma Drugs Market Breakdown, by Medication
    • 11.4.1.11.2 Vietnam: Asthma Drugs Market Breakdown, by Drug Class
    • 11.4.1.11.3 Vietnam: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.4.1.11.4 Vietnam: Asthma Drugs Market Breakdown, by Age Group
  • 11.4.1.12 Bangladesh: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.4.1.12.1 Bangladesh: Asthma Drugs Market Breakdown, by Medication
    • 11.4.1.12.2 Bangladesh: Asthma Drugs Market Breakdown, by Drug Class
    • 11.4.1.12.3 Bangladesh: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.4.1.12.4 Bangladesh: Asthma Drugs Market Breakdown, by Age Group
  • 11.4.1.13 New Zealand: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.4.1.13.1 New Zealand: Asthma Drugs Market Breakdown, by Medication
    • 11.4.1.13.2 New Zealand: Asthma Drugs Market Breakdown, by Drug Class
    • 11.4.1.13.3 New Zealand: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.4.1.13.4 New Zealand: Asthma Drugs Market Breakdown, by Age Group
  • 11.4.1.14 Taiwan : Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.4.1.14.1 Taiwan : Asthma Drugs Market Breakdown, by Medication
    • 11.4.1.14.2 Taiwan : Asthma Drugs Market Breakdown, by Drug Class
    • 11.4.1.14.3 Taiwan : Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.4.1.14.4 Taiwan : Asthma Drugs Market Breakdown, by Age Group
11.5 South and Central America
  • 11.5.1 Asthma Drugs Market Breakdown, by Key Country, 2026 and 2033 (%)
  • 11.5.1.1 Asthma Drugs Market – Revenue and Forecast Analysis – by Country
  • 11.5.1.1 Brazil: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.5.1.1.1 Brazil: Asthma Drugs Market Breakdown, by Medication
    • 11.5.1.1.2 Brazil: Asthma Drugs Market Breakdown, by Drug Class
    • 11.5.1.1.3 Brazil: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.5.1.1.4 Brazil: Asthma Drugs Market Breakdown, by Age Group
  • 11.5.1.2 Argentina: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.5.1.2.1 Argentina: Asthma Drugs Market Breakdown, by Medication
    • 11.5.1.2.2 Argentina: Asthma Drugs Market Breakdown, by Drug Class
    • 11.5.1.2.3 Argentina: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.5.1.2.4 Argentina: Asthma Drugs Market Breakdown, by Age Group
  • 11.5.1.3 Peru: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.5.1.3.1 Peru: Asthma Drugs Market Breakdown, by Medication
    • 11.5.1.3.2 Peru: Asthma Drugs Market Breakdown, by Drug Class
    • 11.5.1.3.3 Peru: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.5.1.3.4 Peru: Asthma Drugs Market Breakdown, by Age Group
  • 11.5.1.4 Chile: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.5.1.4.1 Chile: Asthma Drugs Market Breakdown, by Medication
    • 11.5.1.4.2 Chile: Asthma Drugs Market Breakdown, by Drug Class
    • 11.5.1.4.3 Chile: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.5.1.4.4 Chile: Asthma Drugs Market Breakdown, by Age Group
  • 11.5.1.5 Colombia : Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.5.1.5.1 Colombia : Asthma Drugs Market Breakdown, by Medication
    • 11.5.1.5.2 Colombia : Asthma Drugs Market Breakdown, by Drug Class
    • 11.5.1.5.3 Colombia : Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.5.1.5.4 Colombia : Asthma Drugs Market Breakdown, by Age Group
11.6 Middle East and Africa
  • 11.6.1 Asthma Drugs Market Breakdown, by Key Country, 2026 and 2033 (%)
  • 11.6.1.1 Asthma Drugs Market – Revenue and Forecast Analysis – by Country
  • 11.6.1.1 Bahrain: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.6.1.1.1 Bahrain: Asthma Drugs Market Breakdown, by Medication
    • 11.6.1.1.2 Bahrain: Asthma Drugs Market Breakdown, by Drug Class
    • 11.6.1.1.3 Bahrain: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.6.1.1.4 Bahrain: Asthma Drugs Market Breakdown, by Age Group
  • 11.6.1.2 Kuwait: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.6.1.2.1 Kuwait: Asthma Drugs Market Breakdown, by Medication
    • 11.6.1.2.2 Kuwait: Asthma Drugs Market Breakdown, by Drug Class
    • 11.6.1.2.3 Kuwait: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.6.1.2.4 Kuwait: Asthma Drugs Market Breakdown, by Age Group
  • 11.6.1.3 Oman: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.6.1.3.1 Oman: Asthma Drugs Market Breakdown, by Medication
    • 11.6.1.3.2 Oman: Asthma Drugs Market Breakdown, by Drug Class
    • 11.6.1.3.3 Oman: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.6.1.3.4 Oman: Asthma Drugs Market Breakdown, by Age Group
  • 11.6.1.4 Qatar: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.6.1.4.1 Qatar: Asthma Drugs Market Breakdown, by Medication
    • 11.6.1.4.2 Qatar: Asthma Drugs Market Breakdown, by Drug Class
    • 11.6.1.4.3 Qatar: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.6.1.4.4 Qatar: Asthma Drugs Market Breakdown, by Age Group
  • 11.6.1.5 Saudi Arabia: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.6.1.5.1 Saudi Arabia: Asthma Drugs Market Breakdown, by Medication
    • 11.6.1.5.2 Saudi Arabia: Asthma Drugs Market Breakdown, by Drug Class
    • 11.6.1.5.3 Saudi Arabia: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.6.1.5.4 Saudi Arabia: Asthma Drugs Market Breakdown, by Age Group
  • 11.6.1.6 United Arab Emirates: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.6.1.6.1 United Arab Emirates: Asthma Drugs Market Breakdown, by Medication
    • 11.6.1.6.2 United Arab Emirates: Asthma Drugs Market Breakdown, by Drug Class
    • 11.6.1.6.3 United Arab Emirates: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.6.1.6.4 United Arab Emirates: Asthma Drugs Market Breakdown, by Age Group
  • 11.6.1.7 Turkiye: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.6.1.7.1 Turkiye: Asthma Drugs Market Breakdown, by Medication
    • 11.6.1.7.2 Turkiye: Asthma Drugs Market Breakdown, by Drug Class
    • 11.6.1.7.3 Turkiye: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.6.1.7.4 Turkiye: Asthma Drugs Market Breakdown, by Age Group
  • 11.6.1.8 South Africa: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.6.1.8.1 South Africa: Asthma Drugs Market Breakdown, by Medication
    • 11.6.1.8.2 South Africa: Asthma Drugs Market Breakdown, by Drug Class
    • 11.6.1.8.3 South Africa: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.6.1.8.4 South Africa: Asthma Drugs Market Breakdown, by Age Group
  • 11.6.1.9 Egypt: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.6.1.9.1 Egypt: Asthma Drugs Market Breakdown, by Medication
    • 11.6.1.9.2 Egypt: Asthma Drugs Market Breakdown, by Drug Class
    • 11.6.1.9.3 Egypt: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.6.1.9.4 Egypt: Asthma Drugs Market Breakdown, by Age Group
  • 11.6.1.10 Algeria: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.6.1.10.1 Algeria: Asthma Drugs Market Breakdown, by Medication
    • 11.6.1.10.2 Algeria: Asthma Drugs Market Breakdown, by Drug Class
    • 11.6.1.10.3 Algeria: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.6.1.10.4 Algeria: Asthma Drugs Market Breakdown, by Age Group
  • 11.6.1.11 Nigeria: Asthma Drugs Market – Revenue and Forecast to 2033 (US$ Billion)
    • 11.6.1.11.1 Nigeria: Asthma Drugs Market Breakdown, by Medication
    • 11.6.1.11.2 Nigeria: Asthma Drugs Market Breakdown, by Drug Class
    • 11.6.1.11.3 Nigeria: Asthma Drugs Market Breakdown, by Mode of Administration
    • 11.6.1.11.4 Nigeria: Asthma Drugs Market Breakdown, by Age Group

12. Competitive Landscape

12.1 Heat Map Analysis
12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments

14. Company Profiles

14.1
  • 14.1.1 Key Facts
  • 14.1.2 Business Description
  • 14.1.3 Products and Services
  • 14.1.4 Financial Overview
  • 14.1.5 SWOT Analysis
  • 14.1.6 Key Developments
14.2 GlaxoSmithKline,
  • 14.2.1 Key Facts
  • 14.2.2 Business Description
  • 14.2.3 Products and Services
  • 14.2.4 Financial Overview
  • 14.2.5 SWOT Analysis
  • 14.2.6 Key Developments
14.3 AstraZeneca,
  • 14.3.1 Key Facts
  • 14.3.2 Business Description
  • 14.3.3 Products and Services
  • 14.3.4 Financial Overview
  • 14.3.5 SWOT Analysis
  • 14.3.6 Key Developments
14.4 Sanofi,
  • 14.4.1 Key Facts
  • 14.4.2 Business Description
  • 14.4.3 Products and Services
  • 14.4.4 Financial Overview
  • 14.4.5 SWOT Analysis
  • 14.4.6 Key Developments
14.5 Novartis,
  • 14.5.1 Key Facts
  • 14.5.2 Business Description
  • 14.5.3 Products and Services
  • 14.5.4 Financial Overview
  • 14.5.5 SWOT Analysis
  • 14.5.6 Key Developments
14.6 Merck,
  • 14.6.1 Key Facts
  • 14.6.2 Business Description
  • 14.6.3 Products and Services
  • 14.6.4 Financial Overview
  • 14.6.5 SWOT Analysis
  • 14.6.6 Key Developments
14.7 Teva Pharmaceutical Industries Ltd,
  • 14.7.1 Key Facts
  • 14.7.2 Business Description
  • 14.7.3 Products and Services
  • 14.7.4 Financial Overview
  • 14.7.5 SWOT Analysis
  • 14.7.6 Key Developments
14.8 Boehringer Ingelheim GmbH,
  • 14.8.1 Key Facts
  • 14.8.2 Business Description
  • 14.8.3 Products and Services
  • 14.8.4 Financial Overview
  • 14.8.5 SWOT Analysis
  • 14.8.6 Key Developments
14.9 Pfizer,
  • 14.9.1 Key Facts
  • 14.9.2 Business Description
  • 14.9.3 Products and Services
  • 14.9.4 Financial Overview
  • 14.9.5 SWOT Analysis
  • 14.9.6 Key Developments
14.10 Roche,
  • 14.10.1 Key Facts
  • 14.10.2 Business Description
  • 14.10.3 Products and Services
  • 14.10.4 Financial Overview
  • 14.10.5 SWOT Analysis
  • 14.10.6 Key Developments
14.11 Amgen
  • 14.11.1 Key Facts
  • 14.11.2 Business Description
  • 14.11.3 Products and Services
  • 14.11.4 Financial Overview
  • 14.11.5 SWOT Analysis
  • 14.11.6 Key Developments

15. Appendix

15.1 About Business Market Insights
15.2 List of Abbreviations

Access the Full A Market Report

Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.

Access the full A Market Report
400 pages PDF & Excel | 2026-01-02